Pharming (PHAR) Change in Account Payables (2020 - 2026)

Pharming (PHAR) has 6 years of Change in Account Payables data on file, last reported at $17.8 million in Q4 2025.

• Quarterly Change in Account Payables rose 743.55% year-over-year to $17.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.8 million (up 96.0% YoY) and the FY2025 annual result came in at $14.1 million, up 610.15% from the prior year.
• Change in Account Payables grew to $17.8 million in Q4 2025, from -$2.8 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $17.8 million in Q4 2025 to a low of -$4.0 million in Q4 2021.
• A 5-year average of $2.7 million and a median of -$985884.2 in 2021 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2021 — Change in Account Payables sank 54795.12% — and 2025, when it soared 743.55%.
• Tracing PHAR's Change in Account Payables over 5 years: stood at -$4.0 million in 2021, then surged by 58.94% to -$1.6 million in 2022, then soared by 595.62% to $8.2 million in 2023, then plunged by 133.96% to -$2.8 million in 2024, then surged by 743.55% to $17.8 million in 2025.
• The last three Change in Account Payables figures came in at $17.8 million (Q4 2025), -$2.8 million (Q4 2024), and $6.6 million (Q3 2024), per Business Quant data.